Written and maintained by CASRAI Editorial Board
Last updated
The Biochemical Journal is a peer-reviewed scientific journal published by Portland Press on behalf of the Biochemical Society. Founded in 1906, it publishes original research and reviews exploring the molecular mechanisms of biological processes across biochemistry, cellular biosciences, and molecular biology, utilizing hybrid subscription, Subscribe to Open (S2O), and Read and Publish models.
What it is
The Biochemical Journal (abbreviated Biochem J) is the flagship, longest-running scholarly journal of the Biochemical Society. First published in January 1906, the journal disseminates research in enzymology, metabolism, signal transduction, and molecular genetics. The publication holds National Library of Medicine ID 2984726R, with registered identifiers Print ISSN 0264-6021 and Electronic ISSN 1470-8728.
As a core publication in molecular life sciences, the journal focuses on research providing mechanistic insight into biological pathways rather than purely descriptive observations. It provides a formal scholarly outlet for experimental biology, structural characterization, and novel biochemical methodologies. In addition to primary research papers, the journal publishes commissioned reviews synthesizing major advances in molecular mechanisms.
The journal is indexed across international bibliographic repositories, ensuring discoverability for authors. Understanding what it means for a journal to be indexed helps researchers evaluate the serial’s integration into MEDLINE, PubMed Central (PMC), Scopus, and the Science Citation Index Expanded (SCIE).
Who runs it and what it covers
The Biochemical Journal is published by Portland Press Limited, the wholly owned trading subsidiary and publishing arm of the Biochemical Society, based in London, United Kingdom. Editorial leadership is directed by the Chair of the Editorial Board, Professor Mark Lemmon (Yale University School of Medicine), supported by an international board of active researchers who manage subject-specific peer assessment. Under the society’s governance model, operating surpluses generated by Portland Press are reinvested directly into the life sciences community to finance research grants, student bursaries, and scientific conferences.
The journal’s editorial scope encompasses the breadth of molecular biosciences, structured around fundamental cellular and biochemical processes:
- Enzyme structure and kinetics: Molecular mechanisms of catalysis, allosteric regulation, amino acid metabolism, and enzyme engineering.
- Signal transduction: Protein kinase cascades, G-protein-coupled receptor (GPCR) signaling, lipid signaling, and second-messenger dynamics.
- Cell biology and organelle physiology: Autophagy, intracellular protein trafficking, vesicle dynamics, and mitochondrial bioenergetics.
- Gene expression and molecular genetics: Chromatin organization, transcriptional control, RNA processing, and translation mechanisms.
- Molecular medicine: The biochemical basis of cancer signaling, diabetes, cardiovascular disease, and inflammatory pathways.
Across its publishing history, Crossref records confirm that the Biochemical Journal has deposited more than 35,400 persistent identifier DOIs, while PubMed Central maintains an open archive holding over 56,380 full-text articles.
How to search or use it
Researchers interact with the Biochemical Journal both as literature consumers seeking verified experimental data and as authors submitting manuscripts. Navigating the journal’s platform and submission architecture involves standard workflows across official interfaces:
- Access the journal gateway: Navigate to the official Portland Press journal portal (portlandpress.com/biochemj) or access archives through the Biochemical Society publication directory.
- Search articles and thematic collections: Use the search bar in the top navigation banner to query by author name, keyword, digital object identifier (DOI), or volume/page number.
- Retrieve open archives via PubMed Central: For open-access papers and historical volumes deposited under public access mandates, query the NCBI PMC database using the journal title filter
Biochem J[ta]to inspect full-text records. - Review author guidelines: Prior to submission, inspect current Instructions for Authors on Portland Press, verifying requirements for standardized formatting, reference style (Vancouver numbered system with DOIs), title word limits (maximum 20 words), and abstract structure (under 250 words).
- Prepare data compliance statements: Confirm that your manuscript includes a mandatory Data Availability Statement, documenting public repository deposit accessions (such as PDB or GEO).
- Submit through ScholarOne Manuscripts: Access the journal’s dedicated submission portal on Clarivate’s ScholarOne Manuscripts platform (mc.manuscriptcentral.com/bj), providing institutional email addresses and authenticated ORCID identifiers for corresponding contributors.
- Track editorial review stages: Monitor manuscript progression through editorial screening, single-blind reviewer evaluation, and decision letters via the ScholarOne author dashboard.
Strengths and limits
Evaluating the Biochemical Journal requires examining both its institutional merits as a society-backed journal and the constraints inherent in its publishing framework.
Strengths
- Society-driven non-profit publishing: Surplus revenues directly fund Biochemical Society scientific awards, early-career conferences, and laboratory grants rather than commercial shareholder profits.
- Longstanding bibliographic authority: Continuous publication since 1906 provides archival stability, ensuring citation longevity across academic libraries worldwide.
- Rigorous editorial standards: Editorial oversight is conducted by practicing academic biochemists, supported by 100% automated Crossref Similarity Check (iThenticate) screening to maintain integrity.
- Flexible open-access options: Authors benefit from the Subscribe to Open (S2O) model and extensive institutional Read and Publish agreements, allowing fee-free open-access publishing models for affiliated scholars.
Limits
- Niche disciplinary focus: The journal explicitly prioritizes molecular and mechanistic studies. Purely descriptive organismal biology, clinical observational reports without biochemical dissection, or software-only tools face high initial desk-rejection rates.
- Hybrid access complexities: Because the journal is not a 100% pure gold open-access publication, it is not indexed in the Directory of Open Access Journals (DOAJ), requiring authors to check institutional S2O eligibility to confirm APC waiver status.
- Selective citation tier: While respected, its citation metrics place it in the second quartile (Q2) of biochemistry serials, making it distinct from ultra-high-impact multidisciplinary serials.
Alternatives
Biochemists and molecular biologists have multiple publication venues depending on manuscript scope, turnaround priorities, target audience, and funder open-access mandates. When evaluating options, authors frequently consult resources on finding peer-reviewed journals that match their study design.
| Journal | Publisher | Access Model | Typical Review Model | Scope Focus |
|---|---|---|---|---|
| Biochemical Journal | Portland Press / Biochemical Society | Hybrid / Subscribe to Open (S2O) | Single-blind peer review | Mechanisms in biochemistry, cellular biosciences, and molecular biology |
| Journal of Biological Chemistry (JBC) | Elsevier / ASBMB | Gold Open Access | Single-blind peer review | Molecular and cellular basis of biological processes |
| FEBS Journal | Wiley / FEBS | Hybrid Open Access | Single-blind peer review | Biochemistry, structural biology, and molecular mechanism studies |
| Biochemistry | American Chemical Society (ACS) | Hybrid Open Access | Single-blind peer review | Chemical biology, biophysical chemistry, and synthetic biology interfaces |
| Cellular and Molecular Life Sciences | Springer Nature | Hybrid Open Access | Single-blind peer review | Broad cellular biology, molecular physiology, and biomedical mechanisms |
Frequently asked questions
What is the Biochemical Journal impact factor?
The Biochemical Journal impact factor is 3.9 according to Clarivate’s Journal Citation Reports (JCR), with recent calculation periods recording values between 3.9 and 4.3. The journal maintains a 5-year Impact Factor of approximately 3.9 to 4.4 and a cited half-life exceeding 19 years. In Web of Science subject categorization, the journal ranks in Quartile 2 (Q2) for the Biochemistry & Molecular Biology discipline. Authors can explore methodology details in our guide on how to look up a journal’s impact factor and our breakdown of journal impact factor and quartile rankings.
How does the impact factor of the Biochemical Journal compare to sister titles?
The impact factor biochemical journal metrics place it in the established society-journal tier alongside European and American counterparts like the Journal of Biological Chemistry and FEBS Journal. Within the Portland Press portfolio, it serves as the primary venue for mechanistic discovery, while sister titles such as Biochemical Society Transactions and Essays in Biochemistry focus on commissioned symposium reviews and educational overviews.
Who owns and publishes the Biochemical Journal?
The Biochemical Journal is owned by the Biochemical Society (established in 1911) and published by Portland Press Limited, the society’s wholly owned publishing company. All profits generated from publishing operations are gifted back to the Biochemical Society to support academic science initiatives.
What peer-review model does the Biochemical Journal use?
The journal uses single-blind editorial peer review managed through ScholarOne Manuscripts. Reviewers evaluate manuscripts for technical rigor, biological relevance, data integrity, and originality. Every submission undergoes automated screening through Crossref Similarity Check to prevent duplicate publication.
What manuscript formats does the journal accept?
The journal primarily accepts original Research Papers (typically 10 to 15 published pages) and invited Review Articles. Research manuscripts require detailed experimental protocols, complete statistical reporting, and deposited data accessions. Authors should consult our reference on academic journal article types for common manuscript section taxonomies.
Sources
- National Library of Medicine (NLM) Catalog, The Biochemical Journal (NLM Unique ID: 2984726R; ISSN: 0264-6021 / 1470-8728; read 2026-11-09): https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=nlmcatalog&id=445732
- Biochemical Society, Official Publications and Portland Press Overview (read 2026-11-09): https://www.biochemistry.org/publications/
- NCBI PubMed Central (PMC), Biochemical Journal Open Holdings (Journal ID: 2984726R; read 2026-11-09): https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pmc&term=Biochem+J%5Bta%5D&retmode=json
- Crossref Serial Deposit Record, Biochemical Journal (ISSN: 0264-6021; read 2026-11-09): https://api.crossref.org/journals/0264-6021
- Clarivate Journal Citation Reports (JCR), Biochemical Journal Performance Metrics (Category: Biochemistry & Molecular Biology; read 2026-11-09): https://portlandpress.com/biochemj
